NewAmsterdam Pharma Company
NAMS
$21.82
Share price
-3.32%
Change (1 day)
51.00%
Change (1 year)
Categories
NewAmsterdam Pharma Company (NAMS) - Cash on Hand
Cash on Hand as of December 2023 : $0.34 B
According to NewAmsterdam Pharma Company's latest financial reports the company has $0.34 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
NewAmsterdam Pharma Company - Cash on Hand chart (from 2023 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.34 B | -32.04% |
| 2022-12-31 | $0.50 B | 635.82% |
| 2021-12-31 | $68.07 M | 472.44% |
| 2020-12-31 | $11.89 M |